alprazolam has been researched along with doxepin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barlow, DH; Craske, MG; Zarate, R | 1 |
| Feighner, JP; Rickels, K; Smith, WT | 1 |
| Feighner, JP | 1 |
| Ansoms, C; Ansseau, M; Beckers, G; Bogaerts, M; Botte, L; De Buck, R; Diricq, S; Dumortier, A; Jansegers, E; Owieczka, J | 1 |
| Robb-Nicholson, C | 1 |
| Koval'chuk, VV | 1 |
| Krzek, J; Maślanka, A; Szlósarczyk, M; Wach, K; Żmudzki, P | 1 |
1 review(s) available for alprazolam and doxepin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for alprazolam and doxepin
| Article | Year |
|---|---|
Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression.
Topics: Adult; Alcoholism; Alprazolam; Ambulatory Care; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Doxepin; Female; Humans; Male; Outcome and Process Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Sleep Stages; Tachycardia; Vision Disorders; Xerostomia | 1985 |
Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
Topics: Alprazolam; Amitriptyline; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Doxepin; Humans; Psychiatric Status Rating Scales | 1982 |
Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression.
Topics: Adolescent; Adult; Aged; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Doxepin; Female; Humans; Male; Middle Aged; Psychological Tests | 1984 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplasms; Depression; Doxepin; Emotions; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Mood Disorders; Neurosurgical Procedures; Nialamide; Sertraline; Thiazepines; Trazodone; Treatment Outcome | 2007 |
8 other study(ies) available for alprazolam and doxepin
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Situational exposure treatment versus panic control treatment for agoraphobia. A case study.
Topics: Adaptation, Psychological; Adult; Agoraphobia; Alprazolam; Arousal; Behavior Therapy; Combined Modality Therapy; Desensitization, Psychologic; Doxepin; Fear; Humans; Male; Panic; Social Environment | 1990 |
I read in your June 1997 publication that one of the risk factors for hip fracture is current use of long-acting benzodiazepines. Could you list exactly which medications these are? I take Xanax and doxepin for fibromyalgia. My pharmacist could find no ev
Topics: Alprazolam; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Bone Density; Doxepin; Humans; Osteoporosis; Risk Factors | 1998 |
Dependence of the kinetic and thermodynamic parameters on hydrophilic-lipophilic character of alprazolam, clonazepam, diazepam, doxepin and haloperidol in alkaline environment.
Topics: Alprazolam; Clonazepam; Diazepam; Doxepin; Drug Stability; Haloperidol; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kinetics; Thermodynamics | 2013 |